Showing 7811-7820 of 20409 results for "".
Case in Point: Applying PI3K Combinations in Early Recurrent HR+/HER2- mBC
https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Complement Mediated Kidney Disease Series - A Patient and Caregiver Perspective
https://reachmd.com/programs/cme/complement-mediated-kidney-disease-series-a-patient-and-caregiver-perspective/35709/Complement Mediated Kidney Disease Series - A Patient and Caregiver PerspectiveDupilumab in Preschool Atopic Dermatitis: Real-World Data on Efficacy and Safety
https://reachmd.com/programs/dermconsult/dupilumab-in-preschool-atopic-dermatitis-real-world-data-on-efficacy-and-safety/35497/Symptom Control in gMG: Comparing Ravulizumab and Efgartigimod
https://reachmd.com/programs/neurofrontiers/symptom-control-in-gmg-comparing-ravulizumab-and-efgartigimod/35755/Drawing from the CHAMPION and ADAPT trials, a recent analysis compared symptom control in generalized myasthenia gravis (gMG) patients treated with ravulizumab or efgartigimod. While both biologics demonstrated efficacy, the study found that ravulizumab offered more sustained symptom stability whereNewborn Gene Sequencing: Expanding Early Detection of Treatable Diseases
https://reachmd.com/programs/medical-industry-feature/newborn-gene-sequencing-expanding-early-detection-of-treatable-diseases/29916/Tune in to hear from a variety of pediatric specialists who share perspectives on the GUARDIAN study, which explored the role of genetic testing in newborns.Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
https://reachmd.com/programs/neurofrontiers/gaps-in-schizophrenia-spectrum-disorders-care-a-look-at-causes-and-solutions/32744/Tune in to hear Dr. Natalie Bareis explore gaps in schizophrenia spectrum disorders treatment and how we can expand access to effective care.Diagnosing Muscle Disorders: When to Use Biopsy
https://reachmd.com/programs/neurofrontiers/diagnosing-muscle-disorders-when-to-use-biopsy/26391/Here’s when we should conduct muscle biopsy versus genetic and serological testing to diagnose muscle disorders.The Expanding Role of Peripheral Nerve Stimulation in Acute Pain Control
https://reachmd.com/programs/clinicians-roundtable/the-expanding-role-of-peripheral-nerve-stimulation-in-acute-pain-control/26728/Tune in to learn more about the role of peripheral nerve stimulation in acute pain management.Promising results for self-expanding TAVR device in trial with mostly women
https://reachmd.com/programs/acc-action-center/promising-results-for-self-expanding-tavr-device-in-trial-with-mostly-women/24336/ACC.24 - Hadley Wilson discusses the results of the SMART trial in which 87% were women. In SMART, self-expanding versus balloon-expandable TAVR were compared in patients with a small aortic annulus, most of whom are women.The Gene Messenger: Advancing Neurological Gene Therapy
https://reachmd.com/programs/medical-industry-feature/the-gene-messenger-advancing-neurological-gene-therapy/18094/Hear about groundbreaking advances in neurological gene therapy for patients with Parkinson’s disease.